Why the study?
Does diabetes mellitus increase the risk of death, non-fatal MI, or TVR in patients undergoing PCI with DES, and does this risk vary by ACS presentation?
Does diabetes mellitus increase the risk of death, non-fatal MI, or TVR in patients undergoing PCI with DES, and does this risk vary by ACS presentation?
Diabetes mellitus is associated with worse long-term clinical outcomes after PCI with DES, and this elevated risk is consistent regardless of whether the patient presents with or without an acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
Diabetes mellitus was associated with higher 3-year MACE after DES-PCI irrespective of presentation; leaves open whether targeted strategies improve outcomes in this subgroup.
AIMS: In the drug-eluting stent (DES) era, diabetes mellitus is still associated with poor clinical and angiographic outcome after PCI. Whether this phenomenon is exacerbated in the setting of acute coronary syndromes (ACS) is unclear. We investigated the long-term interaction of diabetes mellitus and clinical presentation in patients treated with percutaneous coronary intervention (PCI). METHODS: Consecutive patients undergoing PCI and DES implantation were retrospectively analyzed. The 3-year composite of death, non-fatal myocardial infarction (MI) or target vessel revascularization (TVR) was assessed. RESULTS: Four subgroups of patients were identified: diabetes mellitus and ACS (n = 302); diabetes mellitus and no-ACS (n = 191); no-diabetes mellitus and ACS (n = 573); no-diabetes mellitus and no-ACS (n = 396). Compared to non-diabetes mellitus, diabetes mellitus patients experienced higher 3-year rates of death, non-fatal MI or TVR (32.3 vs. 21.9%, P < 0.001). Diabetes mellitus was significantly associated with the composite of death, non-fatal MI or TVR in the no-ACS group [adjusted hazard ratio (AHR) 1.307, 95% confidence interval (CI) 1.090-1.566, P = 0.004] and, albeit to a lesser extent, in the ACS group (AHR 1.177, 95% CI 1.006-1.377, P = 0.041). No statistically significant interaction was observed between diabetes mellitus and clinical presentation (P for interaction = 0.802). CONCLUSIONS: No significant interaction between diabetes mellitus and clinical presentation was noted in this study. The high rates of cardiac events observed in diabetes mellitus patients despite recent advances in interventional techniques outline the need for a multidisciplinary approach in the management of diabetes mellitus patients, including optimization of glycemic control, aggressive medical therapy and more complete coronary revascularization.
No takes yet. Share an insight, caveat, or question.
Ruperto et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: